Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
$2.83
+12.3%
$2.07
$1.19
$5.16
$74.08M1.24408,622 shs305,026 shs
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
$23.02
+1.8%
$26.01
$11.92
$34.76
$1.37B0.82774,180 shs1.08 million shs
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$478.96
+2.7%
$449.35
$377.85
$519.88
$119.76B0.411.42 million shs1.04 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
+0.80%+7.69%+11.01%+71.43%-14.58%
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
-1.74%-1.05%-18.70%-10.12%+82.14%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
+1.51%+3.14%+3.52%-3.30%-3.22%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
3.683 of 5 stars
3.52.00.03.41.30.01.3
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
4.1702 of 5 stars
3.01.00.02.43.31.72.5
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
4.3529 of 5 stars
2.35.00.03.33.62.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
3.00
Buy$6.00112.01% Upside
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
2.00
Hold$26.4314.81% Upside
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2.54
Moderate Buy$511.626.82% Upside

Current Analyst Ratings Breakdown

Latest UNFI, CMTL, and VRTX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$550.00
6/20/2025
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$464.00 ➝ $460.00
6/17/2025
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetSector Perform ➝ Sector Perform$423.00 ➝ $420.00
6/12/2025
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$30.00 ➝ $26.00
6/12/2025
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Perform ➝ Market Perform$32.00 ➝ $25.00
6/12/2025
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetHold ➝ Hold$33.00 ➝ $24.00
6/12/2025
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
Northcoast Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
6/11/2025
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$30.00 ➝ $26.00
6/10/2025
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$7.00 ➝ $6.00
5/23/2025
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/7/2025
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
$540.40M0.15$3.08 per share0.92$10.75 per share0.26
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
$30.98B0.05$5.61 per share4.10$27.59 per share0.83
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$11.02B11.16N/AN/A$63.72 per share7.52
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
-$99.99M-$10.02N/AN/AN/A-51.28%-15.38%-3.34%N/A
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
-$112M-$1.15N/A18.72N/A-0.21%3.13%0.66%N/A
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
-$535.60M-$3.92N/A27.35N/A-8.91%-3.36%-2.42%7/30/2025 (Estimated)

Latest UNFI, CMTL, and VRTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/10/2025Q3 2025
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
$0.22$0.44+$0.22-$0.12$7.78 billion$8.06 billion
6/9/2025Q3 2025
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
-$0.30-$0.22+$0.08-$0.49$124.12 million$126.79 million
5/5/2025Q1 2025
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$4.29$4.06-$0.23$2.49$2.85 billion$2.77 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
N/AN/AN/AN/AN/A
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
N/AN/AN/AN/AN/A
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
N/A
0.74
0.53
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
1.21
1.41
0.51
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
0.01
2.65
2.29

Institutional Ownership

CompanyInstitutional Ownership
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
N/A
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
87.63%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
90.96%

Insider Ownership

CompanyInsider Ownership
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
2.10%
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
2.10%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
0.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Comtech Telecommunications Corp. stock logo
CMTL
Comtech Telecommunications
1,67629.40 million28.78 millionOptionable
United Natural Foods, Inc. stock logo
UNFI
United Natural Foods
28,33360.57 million59.29 millionOptionable
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
6,100256.80 million256.28 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Comtech Telecommunications stock logo

Comtech Telecommunications NASDAQ:CMTL

$2.83 +0.31 (+12.30%)
Closing price 04:00 PM Eastern
Extended Trading
$2.82 -0.02 (-0.53%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Comtech Telecommunications Corp., together with its subsidiaries, engages in the provision of next-gen telecommunication solutions in the United States and internationally. The company's Satellite and Space Communications segment offers satellite ground station technologies, services and system integration that facilitates the transmission of voice, video, and data over GEO, MEO and LEO satellite constellations, including solid-state and traveling wave tube power amplifiers, modems, VSAT platforms, and frequency converters; and satellite communications and tracking antenna systems, including high precision full motion fixed and mobile X/Y tracking antennas, RF feeds, reflectors, and radomes. This segment also provides over-the-horizon microwave troposcatter equipment that can transmit digitized voice, video, and data over distances up to 200 miles using the troposphere and diffraction, including the Comtech; and solid-state, RF microwave high-power amplifiers and control components designed for radar, electronic warfare, data link, medical and aviation applications, as well as engages in the procurement and supply chain management of electrical, electronic, and electromechanical parts for satellite, launch vehicle, and manned space applications. Its Terrestrial and Wireless Networks segment offers next generation 911 solutions, which includes emergency call routing, location validation, policy-based routing rules, logging, and security functionality; emergency services IP network transport infrastructure for emergency services communications and support; call handling applications for public safety answering points; wireless emergency alerts solutions for network operators; and software and equipment for location-based and text messaging services for various applications including for public safety, commercial, and government services. The company was founded in 1967 and is headquartered in Melville, New York.

United Natural Foods stock logo

United Natural Foods NYSE:UNFI

$23.02 +0.40 (+1.77%)
Closing price 03:56 PM Eastern
Extended Trading
$23.04 +0.02 (+0.07%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

United Natural Foods, Inc., together with its subsidiaries, distributes natural, organic, specialty, produce, and conventional grocery and non-food products in the United States and Canada. It operates in two segments, Wholesale and Retail. The company offers grocery and general merchandise, produce, perishables and frozen foods, wellness and personal care items, and bulk and foodservice products. It also provides nuts, dried fruit, seeds, trail mixes, granola, natural and organic snack items, and confections under the Woodstock Farms Manufacturing name; organic, non-GMO project verified, and specialty food and non-food items under the Blue Marble brand name; pet food under the WILD HARVEST brand name; and various products under the ESSENTIAL EVERYDAY, SHOPPERS VALUE, Field Day, EQUALINE, CULINARY CIRCLE, and STONE RIDGE CREAMERY brand names. In addition, the company provides home, health and beauty care, and pharmacy products, as well as private label products through a network of Cub Foods and Shoppers retail grocery stores; and retail store support, pricing strategy, shelf and planogram management, advertising, couponing, ecommerce, consumer convenience, store design, equipment sourcing, electronic payments processing, network and data hosting, point-of-sale hardware and software, automation tools, sustainability, and administrative back-office solution services. Further, it offers consumer and trade marketing programs, and programs to support suppliers in understanding its markets. The company serves chains, independent retailers, and supernatural chains, as well as foodservice, ecommerce, conventional military business, and other sales customers. United Natural Foods, Inc. was founded in 1976 and is headquartered in Providence, Rhode Island.

Vertex Pharmaceuticals stock logo

Vertex Pharmaceuticals NASDAQ:VRTX

$478.96 +12.60 (+2.70%)
Closing price 04:00 PM Eastern
Extended Trading
$478.88 -0.08 (-0.02%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.